Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Evans

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Seminars in Oncology|December 1, 1988
Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trialW K Evans
Seminars in Oncology|October 1, 1996
An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancerW K Evans
The Journal of Rheumatology|January 1, 1980
Reversal of hypertrophic osteoarthropathy after chemotherapy for bronchogenic carcinomaW K Evans
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Adjuvant chemotherapy: results and perspectivesW K Evans
Oncology (Williston Park, N.Y.)|April 29, 1998
Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLCW K Evans
Chest|July 1, 1989
Adjuvant therapy for non-small cell lung cancerW K Evans
Praxis|April 20, 2000
Cost-effectiveness analysis in oncologyW K Evans
Chest|January 1, 1993
Management of metastatic non-small-cell lung cancer and a consideration of costW K Evans
Seminars in Oncology|April 1, 1997
Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer moduleW K Evans
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|November 8, 1971
Studies of the effect of gibberellic acid on algal growthW K Evans, C Sorokin
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Seminars in Oncology|December 1, 1988
Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trialW K Evans
Seminars in Oncology|October 1, 1996
An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancerW K Evans
The Journal of Rheumatology|January 1, 1980
Reversal of hypertrophic osteoarthropathy after chemotherapy for bronchogenic carcinomaW K Evans
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Adjuvant chemotherapy: results and perspectivesW K Evans
Oncology (Williston Park, N.Y.)|April 29, 1998
Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLCW K Evans
Chest|July 1, 1989
Adjuvant therapy for non-small cell lung cancerW K Evans
Praxis|April 20, 2000
Cost-effectiveness analysis in oncologyW K Evans
Chest|January 1, 1993
Management of metastatic non-small-cell lung cancer and a consideration of costW K Evans
Seminars in Oncology|April 1, 1997
Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer moduleW K Evans
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|November 8, 1971
Studies of the effect of gibberellic acid on algal growthW K Evans, C Sorokin
Pageof 17